Building Quality Assurance/Quality Control Capacity at the UNM HSC Clinical and Translational Science Center
在 UNM HSC 临床和转化科学中心建立质量保证/质量控制能力
基本信息
- 批准号:10381962
- 负责人:
- 金额:$ 11.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-14 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAffectAreaAwardCenter for Translational Science ActivitiesClinicalClinical ResearchClinical SciencesCollaborationsDataDevelopmentDiagnosticEducationEnvironmentEvaluationEventExtramural ActivitiesFacultyFundingGenerationsGoalsGrantHealth PrioritiesHealth SciencesInstitutionLeadLeadershipMethodsMissionModelingNCI Scholars ProgramNew MexicoOutcomePositioning AttributeProceduresProcessProductivityPublic HealthPublic Health PracticeQuality ControlResearchResearch PersonnelResearch Project GrantsResearch SupportResourcesServicesSpeedSystemTechnical ExpertiseTechnologyTestingTherapeuticThinnessTimeTrainingTranslational ResearchUnderrepresented PopulationsUnited States National Institutes of HealthUniversitiesWomanWorkbaseclinical centerclinical translationdesignhuman diseasehuman subjectimprovedinnovationnoveloperationprogramsquality assurancesuccess
项目摘要
PROJECT SUMMARY/ABSTRACT
The National Institutes of Health’s (NIH) National Center for Advancing Translational Sciences’ (NCATS) goal
is to get more treatments to more people more quickly. However, many of the University of New Mexico (UNM)
Clinical and Translational Science Center’s (CTSC) activities, especially pilot grants and KL2 scholar projects,
require NIH prior approvals that involve very specific submission procedures that, if not implemented precisely,
can lead to delays in study initiation. To address this, the hiring of a full time Quality Assurance/Quality Control
(QA/QC) Manager is proposed. The long-term goal is to provide continual, robust, and efficient continuous
quality improvement in the operations of the UNM CTSC and all interactions with NCATS. The objective is to
improve the quality and efficiency of all CTSC submissions to NCATS. The rationale is that coordination of
CTSC activities with those of NCATS is critical for achieving NIH priorities and enhancing clinical and
translational research (CTR) locally, regionally, and nationally. The objective will be achieved through two
specific aims: 1) Improve the quality, consistency and efficiency of CTSA-required information submitted to
NCATS and the eRA Human Subjects System through the creation of a new, single point-of-contact position;
and 2) Increase the capacity of the UNM CTSC for continuous, data-based improvement through careful
evaluation of outcome metrics related to NCATS submissions, leadership of targeted Lean projects, education
of hub investigators and staff, and sharing of best practices. Under the first aim, a QA/QC Manager will be
hired and oriented, conduct an assessment of factors affecting current submission, develop a comprehensive
QA/QC system for prior approvals including adapting or developing templates, checklists, workflow diagrams,
and standard operating procedures; and actively participate in the NCATS QA/QC Discussion forum and other
Consortium groups. Under the second aim, the Manager will track and evaluate the success of NCATS
submissions; conduct targeted Lean events to continuously improve the quality, consistency, and efficiency of
submissions; develop educational initiatives for CTSC faculty and staff related to prior approvals; and share
best practices with the CTSA Consortium. The approach is innovative because the responsibilities spread
across four positions will now be executed by one manager, who will work in close collaboration with the CTSA
Consortium to design, implement, and evaluate improved submissions using best practices. The proposed
position is significant because it will reduce administrative burden for both NCATS and the CTSC, and speed
translation of CTR into clinical and public health practice.
项目摘要/摘要
美国国立卫生研究院(NIH)国家前进的转化科学中心(NCATS)目标
是为了更快地为更多的人获得更多治疗。但是,新墨西哥大学的许多(UNM)
临床和转化科学中心(CTSC)的活动,尤其是试点赠款和KL2科学项目,
需要NIH事先批准,该批准涉及非常具体的提交程序
可能导致研究计划的延迟。为了解决这个问题,雇用全职质量保证/质量控制
(QA/QC)提出了经理。长期目标是提供连续,健壮,有效的连续
UNM CTSC运营以及与NCAT的所有相互作用的质量提高。目的是
提高所有CTSC提交NCAT的质量和效率。理由是
与NCAT的CTSC活动对于获得NIH的优先级和增强临床和
在本地,区域和全国范围内翻译研究(CTR)。目标将通过两个实现
具体目的:1)提高提交给CTSA的信息的质量,一致性和效率
NCAT和ERA人类受试者通过创建新的,单一接触的位置。
2)通过谨慎提高UNM CTSC进行连续,基于数据的改进的能力
评估与NCAT提交有关的结果指标,目标精益项目的领导,教育
枢纽调查人员和员工,以及最佳实践的共享。在第一个目标下,QA/QC经理将是
雇用和定向,对影响当前提交的因素进行评估,发展全面
QA/QC系统用于事先批准,包括适应或开发模板,清单,工作流程图,
和标准操作程序;并积极参加NCATS QA/QC讨论论坛和其他
财团群体。在第二个目标下,经理将跟踪和评估NCAT的成功
提交;进行有针对性的精益事件,以不断提高质量,一致性和效率
提交;为CTSC的教职员工制定与先前批准有关的教职员工的教育计划;并分享
CTSA财团的最佳实践。这种方法是创新的,因为责任蔓延
现在,跨四个职位将由一位经理执行,他们将与CTSA密切合作。
使用最佳实践来设计,实施和评估改进提交的财团。提议
位置很重要,因为它将减少NCAT和CTSC的管理燃烧,并减少速度
将CTR转换为临床和公共卫生实践。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD S LARSON其他文献
RICHARD S LARSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD S LARSON', 18)}}的其他基金
UNM HSC Clinical and Translational Science Center
新墨西哥大学 HSC 临床和转化科学中心
- 批准号:
10165853 - 财政年份:2015
- 资助金额:
$ 11.71万 - 项目类别:
University of New Mexico Clinical and Translational Science Center
新墨西哥大学临床和转化科学中心
- 批准号:
9257477 - 财政年份:2015
- 资助金额:
$ 11.71万 - 项目类别:
UNM HSC Clinical and Translational Science Center
新墨西哥州 HSC 临床和转化科学中心
- 批准号:
10206291 - 财政年份:2015
- 资助金额:
$ 11.71万 - 项目类别:
University of New Mexico Clinical and Translational Science Center
新墨西哥大学临床和转化科学中心
- 批准号:
9085848 - 财政年份:2015
- 资助金额:
$ 11.71万 - 项目类别:
UNIVERSITY OF NEW MEXICO CLINICAL AND TRANSLATIONAL SCIENCE CENTER
新墨西哥大学临床与转化科学中心
- 批准号:
8365130 - 财政年份:2011
- 资助金额:
$ 11.71万 - 项目类别:
相似国自然基金
区域医疗一体化对基层医疗机构合理用药的影响及优化策略——基于创新扩散理论
- 批准号:72304011
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
高温与臭氧复合暴露对我国心脑血管疾病寿命损失年的区域分异影响及未来风险预估研究
- 批准号:42305191
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
纳米结构和低压协同影响下接触线区域蒸发液体的界面作用和界面传递特性
- 批准号:52376053
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
碳边境调节机制对我国区域经济、社会和环境协调发展的影响——考虑企业所有制异质性的研究
- 批准号:72303240
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
太平洋和大西洋年代际海温模态对大湄公河次区域夏季降水变化的协同影响研究
- 批准号:42375050
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 11.71万 - 项目类别:
Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study
道德伤害综合症创新治疗的实施:2 型混合研究
- 批准号:
10752930 - 财政年份:2024
- 资助金额:
$ 11.71万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 11.71万 - 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 11.71万 - 项目类别:
MAIT cells in lupus skin disease and photosensitivity
MAIT 细胞在狼疮皮肤病和光敏性中的作用
- 批准号:
10556664 - 财政年份:2023
- 资助金额:
$ 11.71万 - 项目类别: